Exploring the Potential Applications of ST13P4 as a Drug Target or Biomarker

Target Name: ST13P4

NCBI ID: G145165

ST13P4

Other Name(s): ST13, Hsp70 interacting protein pseudogene 4 | FAM10A4 | FAM10A4P

Exploring the Potential Applications of ST13P4 as a Drug Target or Biomarker

Staurolactin (ST13) is a protein that plays a crucial role in various cellular processes, including cell signaling, DNA replication, and repair, among others. ST13 is a member of the heat shock protein (Hsp) family, which are known to play a vital role in the regulation of protein stability and dynamics. ST13P4 is a specific pseudogene that is expressed in the brain and is highly conserved across various species.

The ST13P4 protein has been identified as a potential drug target or biomarker due to its unique structure, biology, and expression pattern. In this article, we will discuss the current understanding of ST13P4 and its potential applications as a drug target or biomarker.

Current Knowledge of ST13P4

ST13P4 is a 21-kDa protein that contains 13 unique amino acid residues. It belongs to the Hsp70 family of proteins, which are known for their ability to interact with various molecules, including nucleic acids, proteins, and small molecules. ST13P4 is highly conserved across various species, with the highest identity percentage being 96%.

Expression and localization of ST13P4

ST13P4 is expressed in various tissues and cells, including the brain, heart, liver, and pancreas. It is primarily expressed in the brain, where it is involved in the regulation of synaptic plasticity, memory, and aging. ST13P4 has been shown to localize to the endoplasmic reticulum (ER) and to also be present in the cytoplasm.

Drug Targeting Strategies

Due to its unique structure and biology, ST13P4 has potential as a drug target. One potential approach to drug targeting is to exploit ST13P4's ST13 domain, which is known for its unique catalytic properties. The ST13 domain is involved in the regulation of protein stability and dynamics and has been shown to play a role in various cellular processes, including DNA replication, transcription, and DNA repair.

Another potential approach to drug targeting is to target ST13P4's Hsp70-like domain, which is known to interact with various molecules, including nucleic acids, proteins, and small molecules. This domain is involved in the regulation of protein stability and dynamics and has been shown to play a role in various cellular processes, including stress response, DNA replication, and repair.

Biomarker Applications

ST13P4 has been identified as a potential biomarker due to its unique expression pattern and biology. The expression of ST13P4 is highly conserved across various species, with the highest identity percentage being 96%. This conservation suggests that ST13P4 may be a reliable biomarker for certain diseases.

One potential application of ST13P4 as a biomarker is its involvement in the regulation of synaptic plasticity, memory, and aging. Synaptic plasticity is the ability of the brain to reorganize itself in response to experience, learning, or injury. ST13P4 has been shown to be involved in the regulation of synaptic plasticity and has been linked to the development of various neurological disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia.

Another potential application of ST13P4 as a biomarker is its involvement in stress response. ST13P4 has been shown to be involved in the regulation of stress response and has been linked to the development of various stress-related diseases, including anxiety, depression, and cancer.

Conclusion

In conclusion, ST13P4 is a unique protein that has potential as a drug target or biomarker. Its conserved structure, biology, and expression pattern make it an attractive target for both drug development and biomarker research. Further studies are needed to fully understand the unique properties of ST13P4 and its potential applications as a drug target or biomarker.

Protein Name: ST13, Hsp70 Interacting Protein Pseudogene 4

The "ST13P4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ST13P4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets